Citigroup Raises PT on CR Bard to $95

Symbols: BCR
Tags: Citigroup
Share

Citigroup has raised the price target on CR Bard (NYSE: BCR) from $90 to $95 and maintains its Neutral rating.


 
 
< Previous
UPDATE: Goldman Sachs Raises Target to $19 on PAREXEL International
Next >
UPDATE: Auriga Raises Target on Myriad Genetics to $28
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust